explore -WSS

explore

author：entertainment 2025-10-04 08:14:26 - browse：2149

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round.

The company, BioAge, raised money from more than a dozen investors. Sofinnova Investments led the round, which also included Eli Lilly and Amgen’s venture arms and previous investor Andreessen Horowitz.

BioAge’s primary focus is in developing medications that boost a person’s healthspan, or the number of healthy years a person lives. The company has drugs in development for neuroinflammation and brain aging. But the majority of the Series D proceeds will be used to develop the company’s lead drug candidate azelaprag, which is being tested in combination with Zepbound. That drug program is what grabbed Sofinnova’s attention, according to managing partner Jim Healy, who recently became chairman of BioAge’s board.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Wegovy trial has doctors encouraged over new possibilities

Wikipedia

WSS

The response to Covid

Police still searching for prisoner who escaped from NYC hospital

Where does female orgasm come from? Scientists think they know

Police still searching for prisoner who escaped from NYC hospital

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

knowledge

explore

knowledge

The high cost of giving birth even with insurance

How a key Senate committee is planning to regulate PBMs

Medicare proposal to cover medical devices draws a mixed reaction

How a key Senate committee is planning to regulate PBMs

Bright Health sells Medicare Advantage business to Molina

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Virginia high school admissions case could be legal follow

FDA panel issues narrow recommendation for Covid vaccine booster doses

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In same hospitals, Black patients receive fewer opioids than white patients

Wikipedia

FAMU bans football players from facility after release of rap video shot in team's locker room

Anavex keeps shifting the goalposts in its clinical trials

My chronic pain journey would have been easier knowing 5 things % STAT

How to use technology to prevent future drug shortages

Emergent cuts jobs, executive role in business shake

Men with early prostate cancer can safely opt out of treatment

Wikipedia

Wikipedia

Wikipedia

leisure time